Taclonex Topical Suspension Generic Name & Formulations
Calcipotriene (as hydrate) 0.005% + betamethasone dipropionate 0.064%.
Vit. D3 derivative + topical steroid.
Oint—60g, 100g; Susp—60g, 2x60g
Taclonex Topical Suspension Indications
Plaque psoriasis of the scalp and body.
Taclonex Topical Suspension Dosage and Administration
Adults and Children
<12yrs: not established. Apply to affected areas once daily for up to 8 weeks; discontinue when control is achieved. 12–17yrs: max 60g/week. ≥18yrs: max 100g/week. Do not occlude.
Taclonex Topical Suspension Contraindications
Taclonex Topical Suspension Boxed Warnings
Taclonex Topical Suspension Warnings/Precautions
Avoid use near eyes, on face, groin, or axillae, or if atrophy is present at treatment site. Discontinue if hypercalcemia or hypercalciuria develop; may resume once calcium metabolism has normalized. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, or irritation occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Avoid sun, UV light (eg, phototherapy). Allergic contact dermatitis. Pregnancy. Nursing mothers.
Taclonex Topical Suspension Pharmacokinetics
Taclonex Topical Suspension Interactions
Systemic absorption potentiated by other corticosteroids.
Taclonex Topical Suspension Adverse Reactions
Oint: pruritus, scaly rash. Susp: folliculitis, burning sensation of skin.
Taclonex Topical Suspension Clinical Trials
Taclonex Topical Suspension Note
Taclonex Topical Suspension Patient Counseling